Aveanna Healthcare Navigates Shifting Reimbursement Landscape with Strategic Rate Wins and Payer Partnerships
The home-based care sector is facing increasing financial pressure as both Medicaid budgets and Medicare home health reimbursement rates come under scrutiny. Providers are actively seeking strategies to maintain financial stability amidst these challenges. Aveanna Healthcare (Nasdaq: AVAH) is responding with a multi-pronged approach, securing favorable Medicaid rate adjustments in ten states and establishing eight new preferred payer agreements for private duty services.
The Atlanta-based company, offering a comprehensive suite of pediatric and adult healthcare services across 38 states – including nursing, rehabilitation, and hospice – is focused on proactive financial management. CEO Jeff Shaner indicated the company aims to continue securing double-digit rate increases through legislative efforts in 2026, though anticipates future private duty service (PDS) rate wins will be more modest than those achieved over the past two and a half years. “We’re prepared for that,” Shaner stated during the Q3 earnings call on Thursday.
Looking ahead to 2026, Aveanna projects rate increases in the 2% to 3% range. This projection is coupled with a continued emphasis on building preferred payer relationships, with further partnerships targeted for completion in the fourth quarter of 2025. This strategy is crucial in a market where securing favorable contracts with insurance providers is paramount to profitability.
The Evolving Dynamics of Home Healthcare Reimbursement
The pressures facing home healthcare providers are multifaceted. Declining reimbursement rates from both Medicare and Medicaid, coupled with rising operational costs – particularly labor – are squeezing margins. This environment necessitates innovative strategies to ensure continued access to care for vulnerable populations. One key trend is the shift towards value-based care models, where providers are rewarded for quality outcomes rather than volume of services. Another is the increasing importance of preferred payer agreements, which offer more predictable and often higher reimbursement rates.
Aveanna’s focus on episodic admissions – now exceeding 70% – is a testament to this strategic shift. According to Chief Financial Officer Matt Buckhalter, this approach has “right-sized our margin profile and enhanced our clinical offerings.” Episodic care, where reimbursement is tied to a specific episode of illness or recovery, allows for more accurate cost accounting and potentially higher revenue compared to traditional fee-for-service models.
The company’s Q3 performance reflects this strategic direction. Aveanna reported total revenue of $621.9 million, a 22.2% increase year-over-year. The private duty segment, in particular, experienced significant growth, generating approximately $514 million in revenue – a 25.6% year-over-year increase. The home health and hospice segment also contributed positively, with revenue reaching $62.4 million, a 15.3% increase.
Despite the positive momentum, uncertainty surrounding the proposed 2026 Medicare rate cut remains a concern for many home health companies. Aveanna leaders, however, anticipate a minimal impact, expecting the final rule to be “somewhere close to neutral to zero,” following productive discussions with legislators. This uncertainty has temporarily paused acquisition strategies across the industry, including at Aveanna.
“For all of us, it’s just getting certainty,” Shaner explained. “Just give us a certain answer that we can read into the future with this administration, and then we’re ready to go to work.” The company is on track to fully integrate Thrive Skilled Pediatric Care, acquired earlier this year, by the end of 2025, and plans to pursue further acquisitions in 2026 to expand its Medicaid footprint.
What innovative strategies will be most critical for home health agencies to thrive in the face of ongoing reimbursement challenges? And how can technology play a role in improving efficiency and care quality within the home health setting?
Frequently Asked Questions About Aveanna Healthcare and Home Health Reimbursement
A: Aveanna Healthcare is focusing on securing favorable Medicaid rate adjustments in multiple states, establishing preferred payer agreements, and optimizing its care delivery model through episodic admissions.
A: Aveanna’s private duty segment has experienced significant growth, generating approximately $514 million in revenue during Q3, representing a 25.6% increase year-over-year.
A: Aveanna anticipates rate increases in the range of 2% to 3% in 2026.
A: Uncertainty surrounding the proposed Medicare rate cut has caused Aveanna to pause its acquisition strategies until a final rule is announced.
A: Focusing on episodic admissions allows Aveanna to better manage costs, enhance clinical offerings, and improve its overall margin profile.
A: Aveanna Healthcare offers a wide range of services, including nursing, rehabilitation, occupational therapy, therapy services, day treatment, and home health and hospice care for both pediatric and adult patients.
Disclaimer: This article provides general information and should not be considered financial or medical advice. Consult with a qualified professional for personalized guidance.
Share this article with your network to spark a conversation about the future of home healthcare! What are your thoughts on Aveanna’s strategy? Leave a comment below and let us know.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
